Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Validation of the Aptitude Medical Systems Metrix COVID/Flu Test for Detection of SARS-CoV-2 and Influenza A/B in Point-of-Care and Non-Laboratory Settings

NCT06191393 is registered in ClinicalTrials.gov with Aptitude Medical Systems as lead sponsor.

NCT NCT06191393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06191393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Validation of the Aptitude Medical Systems Metrix COVID/Flu Test for Detection of SARS-CoV-2 and Influenza A/B in Point-of-Care and Non-Laboratory Settings
Lead sponsor
Aptitude Medical Systems
Phase
Not applicable
Overall status
Completed
Start date
November 20, 2023
Completion date
March 11, 2025
Enrollment
614 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

influenza a, influenza b, sars-cov-2 infection